NDAINTRAVENOUSPOWDERPriority Review
Approved
Nov 2019
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
4/8 — Partial
Priority Review
Drug data last refreshed 20h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FETROJA (cefiderocol sulfate tosylate) is a siderophore cephalosporin antibiotic administered intravenously as a powder for reconstitution. It is indicated for treatment of serious bacterial infections, particularly those caused by multidrug-resistant gram-negative pathogens. The drug utilizes a novel siderophore-mediated uptake mechanism to penetrate bacterial cell walls and evade resistance mechanisms.
$0.004BPart D
Peak8.8 years to LOEThe product is in peak commercial lifecycle with modest Part D penetration (~1,000 claims annually), suggesting a specialized hospital-focused franchise with stable but limited market growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on FETROJA offers exposure to hospital-based specialty pharmaceuticals, infectious disease markets, and quality/regulatory operations focused on sterile IV products. Career paths emphasize account management, hospital partnerships, and operational excellence over traditional field sales, with emerging roles in digital infrastructure and data management.
Director
Worked on FETROJA at Shionogi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.